Evidence map›Paper›PMID 38567259›Full record

ArticleRSC advances2024

Heterocyclic (pyrazine)carboxamide Ru(ii) complexes: structural, experimental and theoretical studies of interactions with biomolecules and cytotoxicity.

Nokwanda Tsaulwayo, Reinner O Omondi, Paranthaman Vijayan, Nicole R S Sibuyi, Miché D Meyer, Mervin Meyer, Stephen O Ojwach

Open access · goldAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in RSC advances, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
1.7field-weighted citation impact, top 14% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed, 6 citations in OpenAlex.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 2 institutions in 1 country.

Nokwanda TsaulwayoSchool of Chemistry and Physics, University of KwaZulu-Natal Private Bag X01, Scottsville Pietermaritzburg 3209 South Africa ojwach@ukzn.ac.za.
Reinner O OmondiSchool of Chemistry and Physics, University of KwaZulu-Natal Private Bag X01, Scottsville Pietermaritzburg 3209 South Africa ojwach@ukzn.ac.za.ORCID https://orcid.org/0000-0002-9858-802X
Paranthaman VijayanSchool of Chemistry and Physics, University of KwaZulu-Natal Private Bag X01, Scottsville Pietermaritzburg 3209 South Africa ojwach@ukzn.ac.za.ORCID https://orcid.org/0000-0002-4375-9629
Nicole R S SibuyiDepartment of Science and Innovation/Mintek Nanotechnology Innovation Centre, Biolabels Research Node, Department of Biotechnology, University of the Western Cape Bag X17, Bellville 7535 Cape Town South Africa.ORCID https://orcid.org/0000-0001-7175-5388
Miché D MeyerDepartment of Science and Innovation/Mintek Nanotechnology Innovation Centre, Biolabels Research Node, Department of Biotechnology, University of the Western Cape Bag X17, Bellville 7535 Cape Town South Africa.
Mervin MeyerDepartment of Science and Innovation/Mintek Nanotechnology Innovation Centre, Biolabels Research Node, Department of Biotechnology, University of the Western Cape Bag X17, Bellville 7535 Cape Town South Africa.
Stephen O OjwachSchool of Chemistry and Physics, University of KwaZulu-Natal Private Bag X01, Scottsville Pietermaritzburg 3209 South Africa ojwach@ukzn.ac.za.ORCID https://orcid.org/0000-0001-5309-4926
University of KwaZulu-Natal · ZAMintek · ZA

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Treatments of

Identifiers

PMID38567259
PMCPMC10985535
OpenAlexW4392645780

What Socratic holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.